Polymeric particulates to improve oral bioavailability of peptide drugs

Oral administration remains the most convenient way of delivering drugs. Recent advances in biotechnology have produced highly potent new molecules such as peptides, proteins and nucleic acids. Due to their sensitivity to chemical and enzymatic hydrolysis as well as a poor cellular uptake, their ora...

Full description

Saved in:
Bibliographic Details
Published in:Molecules (Basel, Switzerland) Vol. 10; no. 1; pp. 65 - 80
Main Authors: Delie, Florence, Blanco-Príeto, María José
Format: Journal Article Book Review
Language:English
Published: Switzerland MDPI AG 31-01-2005
MDPI
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Oral administration remains the most convenient way of delivering drugs. Recent advances in biotechnology have produced highly potent new molecules such as peptides, proteins and nucleic acids. Due to their sensitivity to chemical and enzymatic hydrolysis as well as a poor cellular uptake, their oral bioavailability remains very low. Despite sophisticated new delivery systems, the development of a satisfactory oral formulation remains a challenge. Among the possible strategies to improve the absorption of drugs, micro- and nanoparticles represent an exciting approach to enhance the uptake and transport of orally administered molecules. Increasing attention has been paid to their potential use as carriers for peptide drugs for oral administration. This article reviews the most common manufacturing methods for polymeric particles and the physiology of particle absorption from the gastrointestinal (GI) tract. In a second part, the use of polymeric particulate systems to improve the oral absorption of insulin is discussed.
AbstractList Oral administration remains the most convenient way of delivering drugs. Recent advances in biotechnology have produced highly potent new molecules such as peptides, proteins and nucleic acids. Due to their sensitivity to chemical and enzymatic hydrolysis as well as a poor cellular uptake, their oral bioavailability remains very low. Despite sophisticated new delivery systems, the development of a satisfactory oral formulation remains a challenge. Among the possible strategies to improve the absorption of drugs, micro- and nanoparticles represent an exciting approach to enhance the uptake and transport of orally administered molecules. Increasing attention has been paid to their potential use as carriers for peptide drugs for oral administration. This article reviews the most common manufacturing methods for polymeric particles and the physiology of particle absorption from the gastrointestinal (GI) tract. In a second part, the use of polymeric particulate systems to improve the oral absorption of insulin is discussed.
Oral administration remains the most convenient way of delivering drugs. Recent advances in biotechnology have produced highly potent new molecules such as peptides, proteins and nucleic acids. Due to their sensitivity to chemical and enzymatic hydrolysis as well as a poor cellular uptake, their oral bioavailability remains very low. Despite sophisticated new delivery systems, the development of a satisfactory oral formulation remains a challenge. Among the possible strategies to improve the absorption of drugs, micro- and nanoparticles represent an exciting approach to enhance the uptake and transport of orally administered molecules. Increasing attention has been paid to their potential use as carriers for peptide drugs for oral administration. This article reviews the most common manufacturing methods for polymeric particles and the physiology of particle absorption from the gastrointestinal (GI) tract. In a second part, the use of polymeric particulate systems to improve the oral absorption of insulin is discussed.
Author Delie, Florence
Blanco-Príeto, María José
AuthorAffiliation 1 School of Pharmacy, 30, Quai E. Ansermet, CH-1211 Geneva 4, Switzerland, Phone: (+41) 22 379 6573, Fax: (+41) 22 379 6567, E-mail: Florence.Delie@pharm.unige.ch
2 Centro Galénico, Farmacia y Tecnología Farmacéutica, Universidad de Navarra; Ap. 177, 31080 – Pamplona, Spain, Phone: (+34) 948 42 56 00, Fax: (+34) 948 42 56 49
AuthorAffiliation_xml – name: 1 School of Pharmacy, 30, Quai E. Ansermet, CH-1211 Geneva 4, Switzerland, Phone: (+41) 22 379 6573, Fax: (+41) 22 379 6567, E-mail: Florence.Delie@pharm.unige.ch
– name: 2 Centro Galénico, Farmacia y Tecnología Farmacéutica, Universidad de Navarra; Ap. 177, 31080 – Pamplona, Spain, Phone: (+34) 948 42 56 00, Fax: (+34) 948 42 56 49
Author_xml – sequence: 1
  givenname: Florence
  surname: Delie
  fullname: Delie, Florence
  email: Florence.Delie@pharm.unige.ch
  organization: School of Pharmacy, 30, Quai E. Ansermet, CH-1211 Geneva 4, Switzerland. Florence.Delie@pharm.unige.ch
– sequence: 2
  givenname: María José
  surname: Blanco-Príeto
  fullname: Blanco-Príeto, María José
BackLink https://www.ncbi.nlm.nih.gov/pubmed/18007277$$D View this record in MEDLINE/PubMed
BookMark eNpVkU9r3DAQxUVJaJJtoZ-gGHrJZRONZEneS6GE_IOF5JCexVgab7V4LVe2F_bbR8lum4QRzCA9fqPHO2NHXeyIsW_AL6Rc8EvgPB-tPrFTKAWfS14ujt7NJ-xsGNacCyhBfWYnUHFuhDGn7PYxtrsNpeCKHtMY3NTiSEMxxiJs-hS3VMSEbVGHiFsMLdahDeOuiE3RUz8GT4VP02r4wo4bbAf6eugz9vvm-unqbr58uL2_-rWcOyX5OAeBKMTClZ5ACy1JV0DkFRlfl4iOUHBFHhw6j0ZrpVVTg_DGCF8jVXLG7vdcH3Ft-xQ2mHY2YrCvFzGt7KuNluwCRWU8NiRNXXqfeR5Lchwdd8YDZdbPPauf6g15R92YrX6Afnzpwh-7iluroTRK6Qz4cQCk-HeiYbTrOKUu-7egJACvcmXV-V7lUhyGRM3_DcDtS3z2X3xZ-v39j96Eh7zkM340mQw
CitedBy_id crossref_primary_10_1007_s12668_013_0084_7
crossref_primary_10_1517_17425247_5_1_45
crossref_primary_10_1111_apm_12351
crossref_primary_10_4103_0975_1483_83765
crossref_primary_10_1371_journal_pone_0194298
crossref_primary_10_1080_01932691003757314
crossref_primary_10_1016_j_maturitas_2012_05_014
crossref_primary_10_2165_11539070_000000000_00000
crossref_primary_10_1002_rcm_4544
crossref_primary_10_1007_s13346_021_01056_8
crossref_primary_10_1517_13543784_2010_517745
crossref_primary_10_1007_s11051_017_3901_z
crossref_primary_10_1016_j_carbpol_2014_12_044
crossref_primary_10_1002_jps_21347
crossref_primary_10_1002_jemt_20529
crossref_primary_10_1177_0883911511430537
crossref_primary_10_1002_wnan_1315
crossref_primary_10_1016_j_nano_2012_07_005
crossref_primary_10_3390_molecules191117848
crossref_primary_10_1007_s11095_012_0943_x
crossref_primary_10_1248_bpb_29_1790
crossref_primary_10_1016_j_ejps_2010_06_010
crossref_primary_10_3109_10717544_2014_970297
crossref_primary_10_1590_S0104_14282011005000060
crossref_primary_10_2478_v10007_007_0013_9
crossref_primary_10_1016_j_ijpharm_2010_12_010
crossref_primary_10_3109_03639045_2015_1081234
crossref_primary_10_1016_j_bbapap_2007_08_007
crossref_primary_10_1080_17425247_2018_1503249
crossref_primary_10_1080_02652040802485485
crossref_primary_10_1021_mp100253e
crossref_primary_10_1080_02652040600682390
crossref_primary_10_1016_j_carbpol_2015_01_066
crossref_primary_10_1021_acs_molpharmaceut_7b00458
crossref_primary_10_4103_0253_7613_71887
crossref_primary_10_1002_jbm_a_33052
crossref_primary_10_1002_pi_2273
crossref_primary_10_1211_jpp_59_4_0002
crossref_primary_10_3390_ma16093382
crossref_primary_10_1007_s10792_013_9829_0
crossref_primary_10_3109_03639045_2013_841187
crossref_primary_10_1021_cr900327d
crossref_primary_10_1039_D3BM00191A
crossref_primary_10_1211_jpp_59_12_0002
crossref_primary_10_3109_10717544_2011_577108
crossref_primary_10_1016_j_addr_2017_05_004
crossref_primary_10_1088_0957_4484_21_6_065104
crossref_primary_10_1590_s1517_707620190003_0712
crossref_primary_10_1002_mabi_200700022
crossref_primary_10_1007_s11095_010_0358_5
crossref_primary_10_1016_j_ijbiomac_2014_08_053
crossref_primary_10_1016_j_jconrel_2017_09_003
crossref_primary_10_1016_j_carbpol_2020_117504
crossref_primary_10_1155_2017_5813793
crossref_primary_10_1007_s11095_007_9367_4
crossref_primary_10_1016_j_addr_2009_11_023
crossref_primary_10_1155_2017_7120815
crossref_primary_10_2217_nnm_09_110
crossref_primary_10_3109_08982104_2013_805339
crossref_primary_10_1089_jop_2011_0215
crossref_primary_10_1039_b9nr00407f
crossref_primary_10_1517_17425247_2012_717068
crossref_primary_10_1016_j_drudis_2012_03_019
crossref_primary_10_1080_10611860600864182
crossref_primary_10_3390_ijms151018040
crossref_primary_10_1016_j_vaccine_2011_05_098
crossref_primary_10_1080_17435390802398309
crossref_primary_10_3109_03639045_2012_699069
crossref_primary_10_1007_s11095_008_9620_5
crossref_primary_10_1002_pola_23786
crossref_primary_10_3109_03639045_2014_947507
crossref_primary_10_2174_1573412915666190314124932
crossref_primary_10_1517_17425247_2015_1068287
crossref_primary_10_1016_j_ijpharm_2016_01_028
crossref_primary_10_1016_j_ijpharm_2014_06_035
crossref_primary_10_1016_j_colsurfb_2012_03_024
crossref_primary_10_1590_S1984_82502015000200024
crossref_primary_10_1016_j_ddtec_2008_11_005
Cites_doi 10.1038/sj.bjp.0700910
10.1023/A:1015897900363
10.1046/j.1463-1326.2000.00080.x
10.1248/cpb.46.1613
10.1016/S0168-3659(96)01475-7
10.3109/10611869308996082
10.1016/0168-3659(90)90133-E
10.1136/gut.6.3.225
10.1016/0264-410X(92)90021-B
10.1023/A:1011934328471
10.1111/j.2042-7158.1990.tb07033.x
10.1021/jm00021a014
10.1111/j.2042-7158.1979.tb13510.x
10.1002/(SICI)1098-2299(200002)49:2<109::AID-DDR4>3.0.CO;2-#
10.1006/meth.1999.0786
10.1016/0168-3659(90)90013-J
10.1016/S0378-5173(99)00118-0
10.3109/02652049609026049
10.1080/15287398009529888
10.1016/S0378-5173(99)00049-6
10.1021/js980337n
10.1159/000196856
10.1016/0168-3659(93)90190-G
10.1016/0378-5173(86)90236-X
10.1038/386410a0
10.1016/S1054-3589(08)60188-X
10.3109/03639048209022119
10.1016/0168-3659(96)01368-5
10.1016/S0378-5173(00)00627-X
10.1111/j.2042-7158.1991.tb05437.x
10.1016/0168-3659(96)01342-9
10.1023/A:1018986226557
10.1007/978-1-4684-5344-7_30
10.1023/A:1018826103261
10.1016/S0928-0987(97)10007-0
10.1016/S0169-409X(98)00042-8
10.1002/jps.2600651115
10.1016/S0939-6411(98)00064-2
10.1023/A:1007582332491
10.1159/000135938
10.3109/10611860108997924
10.1016/0169-409X(91)90048-H
10.1111/j.1749-6632.1975.tb51092.x
10.1081/DDC-100102197
10.1016/S0378-5173(02)00002-9
10.1021/jm00021a015
10.1002/jps.2600841202
10.1016/0168-3659(91)90028-C
10.1016/S0169-409X(98)00041-6
10.1023/A:1015846810474
10.1016/S0169-409X(98)00039-8
10.1016/S0169-409X(98)00045-3
10.1159/000196836
10.1023/A:1012126301290
10.1023/A:1016073416332
10.1128/iai.56.1.278-282.1988
10.3109/02652049809008242
10.1016/0378-5173(94)00104-9
10.1016/S0168-3659(00)00339-4
10.1051/parasite/1998053223
10.2337/diab.37.2.246
10.1016/S0168-3659(99)00247-3
ContentType Journal Article
Book Review
Copyright Copyright MDPI AG 2005
2005 by MDPI (http://www.mdpi.org). 2005
Copyright_xml – notice: Copyright MDPI AG 2005
– notice: 2005 by MDPI (http://www.mdpi.org). 2005
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7X7
7XB
88E
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
M1P
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
5PM
DOA
DOI 10.3390/10010065
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Databases
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
DatabaseTitleList MEDLINE


Publicly Available Content Database
CrossRef
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: ECM
  name: MEDLINE
  url: https://search.ebscohost.com/login.aspx?direct=true&db=cmedm&site=ehost-live
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Chemistry
EISSN 1420-3049
EndPage 80
ExternalDocumentID oai_doaj_org_article_9a287dafe37b4ddda7da4ec0ac0c7d1e
3321822561
10_3390_10010065
18007277
Genre Evaluation Studies
Journal Article
Review
GroupedDBID ---
0R~
123
2WC
3V.
53G
5VS
7X7
88E
8FE
8FG
8FH
8FI
8FJ
AADQD
AAFWJ
AAHBH
ABJCF
ABUWG
ACGFO
ACIWK
ACPRK
AEGXH
AENEX
AFKRA
AFPKN
AFRAH
AFZYC
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
BBNVY
BENPR
BHPHI
BPHCQ
BVXVI
C1A
CCPQU
CGR
CS3
CUY
CVF
D1I
DIK
DU5
E3Z
ECM
EIF
ESX
FYUFA
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
HZ~
I09
IPNFZ
KB.
KQ8
LK8
M1P
M7P
MODMG
M~E
NPM
O-U
O9-
OK1
P2P
PDBOC
PIMPY
PQQKQ
PROAC
PSQYO
RIG
RPM
TR2
UKHRP
AAYXX
CITATION
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQUKI
PRINS
5PM
ID FETCH-LOGICAL-c530t-12aa229c4de16263e681eed5e7db4aacea205ed1cacda766565fb12d772dbae83
IEDL.DBID RPM
ISSN 1420-3049
IngestDate Tue Oct 22 15:08:36 EDT 2024
Tue Sep 17 20:58:32 EDT 2024
Tue Nov 19 06:07:00 EST 2024
Thu Nov 21 21:09:06 EST 2024
Sat Sep 28 08:36:44 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License Reproduction is permitted for noncommercial purposes.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c530t-12aa229c4de16263e681eed5e7db4aacea205ed1cacda766565fb12d772dbae83
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6147556/
PMID 18007277
PQID 1531108080
PQPubID 2032355
PageCount 16
ParticipantIDs doaj_primary_oai_doaj_org_article_9a287dafe37b4ddda7da4ec0ac0c7d1e
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6147556
proquest_journals_1531108080
crossref_primary_10_3390_10010065
pubmed_primary_18007277
PublicationCentury 2000
PublicationDate 20050131
PublicationDateYYYYMMDD 2005-01-31
PublicationDate_xml – month: 1
  year: 2005
  text: 20050131
  day: 31
PublicationDecade 2000
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Molecules (Basel, Switzerland)
PublicationTitleAlternate Molecules
PublicationYear 2005
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Leroux (ref_63) 1995; 84
Vranckx (ref_29) 1996; 42
Kreuter (ref_8) 1976; 11
Zimmer (ref_11) 1999; 18
Eldridge (ref_62) 1990; 11
Volkheimer (ref_39) 1975; 246
Delie (ref_51) 1998; 34
Ammoury (ref_26) 1991; 8
Barichello (ref_66) 1999; 25
Volkheimer (ref_35) 1977; 14
Carino (ref_60) 2000; 65
Couvreur (ref_7) 1979; 31
Rafati (ref_13) 1997; 43
McGhee (ref_42) 1997; 10
Leroux (ref_2) 1998; 34
Couvreur (ref_5) 1995; 41
Hillery (ref_20) 1996; 42
Kim (ref_65) 1997; 120
McInnes (ref_76) 1995; 38
(ref_44) 1998; 34
Jani (ref_49) 1990; 42
Oppenheim (ref_19) 1982; 8
Fessi (ref_27) 1986; 2
LeFevre (ref_50) 1980; 6
Couvreur (ref_54) 2001; 9
Cornes (ref_36) 1965; 6
Ma (ref_61) 2000; 2
Milstein (ref_77) 1996; 13
Soppimath (ref_6) 2001; 70
Alonso (ref_4) 1996; 77
Michel (ref_23) 1988; 37
Leroux (ref_33) 1999; 16
Vonderscher (ref_58) 1997; 49
Eldridge (ref_43) 1989; 146
Volkheimer (ref_40) 1968; 1
Lowman (ref_72) 1999; 88
Lambert (ref_30) 2000; 17
Kissel (ref_16) 1991; 16
Fessi (ref_25) 1986; 28
Doelker (ref_28) 1998; 15
Michel (ref_24) 1991; 43
Magenheim (ref_31) 1991; 1
Gupta (ref_18) 1993; 26
Hubert (ref_67) 1991; 8
Orsolini (ref_17) 1999; 184
Ford (ref_22) 1999; 183
Nagareya (ref_73) 1998; 46
Jepson (ref_45) 1993; 1
Couvreur (ref_55) 1980; 26
Singh (ref_70) 1998; 15
Delie (ref_14) 2001; 214
Lescure (ref_9) 1994; 11
Volkheimer (ref_37) 1968; 1
Kreuter (ref_34) 1991; 7
Aboubakar (ref_57) 2000; 49
Beck (ref_69) 1994; 40
Delie (ref_12) 1994; 111
Wells (ref_48) 1988; 56
Watnasirichaikul (ref_59) 2002; 235
McClean (ref_46) 1998; 6
Delie (ref_52) 1996; 23
Berton (ref_10) 1999; 47
Jeurissen (ref_47) 1987; 216A
Sordet (ref_64) 1998; 5
Hillery (ref_21) 1996; 41
Volkheimer (ref_38) 1968; 1
Simecka (ref_41) 1998; 34
Bruhn (ref_15) 1991; 18
Santiago (ref_75) 1995; 38
Maas (ref_68) 1997; 5
Mathiowitz (ref_74) 1997; 386
Lee (ref_1) 1988; 5
Fessi (ref_32) 1995; 5
Gurny (ref_3) 1993; 39
Leroux (ref_71) 1996; 13
Michel (ref_56) 1990; 13
Desai (ref_53) 1997; 14
References_xml – volume: 120
  start-page: 399
  year: 1997
  ident: ref_65
  article-title: The Antihypertensive Effect of Orally Administered Nifedipine-Loaded Nanoparticles in Spontaneously Hypertensive Rats
  publication-title: Brit. J. Pharmacol.
  doi: 10.1038/sj.bjp.0700910
  contributor:
    fullname: Kim
– volume: 23
  start-page: 149
  year: 1996
  ident: ref_52
  article-title: Caco-2 Monolayers As a Tool to Examine Intestinal Uptake of Particulates
  publication-title: Proceed. Intern. Symp. Control. Rel. Bioact. Mater.
  contributor:
    fullname: Delie
– volume: 8
  start-page: 734
  year: 1991
  ident: ref_67
  article-title: The Preparation and Acute Antihypertensive Effects of a Nanocapsular Form of Darodipine, a Dihydropyridine Calcium Entry Blocker
  publication-title: Pharm Res
  doi: 10.1023/A:1015897900363
  contributor:
    fullname: Hubert
– volume: 2
  start-page: 243
  year: 2000
  ident: ref_61
  article-title: Preliminary Study of Oral Polylactide Microcapsulated Insulin in Vitro and in Vivo
  publication-title: Diabetes Obes. Metab.
  doi: 10.1046/j.1463-1326.2000.00080.x
  contributor:
    fullname: Ma
– volume: 46
  start-page: 1613
  year: 1998
  ident: ref_73
  article-title: Preparation and Characterization of Enteric Microspheres Containing Bovine Insulin by a w/o/w Emulsion Solvent Evaporation Method
  publication-title: Chem. Pharm. Bull.
  doi: 10.1248/cpb.46.1613
  contributor:
    fullname: Nagareya
– volume: 43
  start-page: 89
  year: 1997
  ident: ref_13
  article-title: Protein-Loaded Poly(DL-Lactide-Co-Glycolide) Microparticles for Oral Administration: Formulation, Structural and Release Characteristics
  publication-title: J. Contr. Rel.
  doi: 10.1016/S0168-3659(96)01475-7
  contributor:
    fullname: Rafati
– volume: 1
  start-page: 245
  year: 1993
  ident: ref_45
  article-title: Comparison of Poly(DL-Lactide-Co-Glycolide) and Polystyrene Microsphere Targeting to Intestinal M Cells
  publication-title: J. Drug Targ.
  doi: 10.3109/10611869308996082
  contributor:
    fullname: Jepson
– volume: 11
  start-page: 205
  year: 1990
  ident: ref_62
  article-title: Controlled Vaccine Release in the Gut-Associated Lymphoid Tissues. 1. Orally Administered Biodegradable Microspheres Target the Peyer's Patches
  publication-title: J. Contr. Rel.
  doi: 10.1016/0168-3659(90)90133-E
  contributor:
    fullname: Eldridge
– volume: 6
  start-page: 225
  year: 1965
  ident: ref_36
  article-title: Number, Size, and Distribution of Peyer's Patches in the Human Small Intestine
  publication-title: Gut
  doi: 10.1136/gut.6.3.225
  contributor:
    fullname: Cornes
– volume: 10
  start-page: 75
  year: 1997
  ident: ref_42
  article-title: The Mucosal Immune System: From Fundamental Concepts to Vaccine Development
  publication-title: Vaccine
  doi: 10.1016/0264-410X(92)90021-B
  contributor:
    fullname: McGhee
– volume: 15
  start-page: 1056
  year: 1998
  ident: ref_28
  article-title: Preparation and Characterization of Nanocapsules From Preformed Polymers by a New Process Based on Emulsification-Diffusion Technique
  publication-title: Pharm.Res.
  doi: 10.1023/A:1011934328471
  contributor:
    fullname: Doelker
– volume: 42
  start-page: 821
  year: 1990
  ident: ref_49
  article-title: Nanoparticles Uptake by the Rat Gastrointestinal Mucosa: Quantitation and Particle Size Dependency
  publication-title: J. Pharm. Pharmacol.
  doi: 10.1111/j.2042-7158.1990.tb07033.x
  contributor:
    fullname: Jani
– volume: 5
  start-page: 242
  year: 1995
  ident: ref_32
  article-title: Gastro-Intestinal Tolerance Study of a Freeze-Dried Oral Dosage Form of Indomethacin-Loaded Nanocapsules
  publication-title: S. T. P. Pharma Sciences
  contributor:
    fullname: Fessi
– volume: 38
  start-page: 4257
  year: 1995
  ident: ref_76
  article-title: Microsphere Formation in a Series of Derivatized α-Amino Acids: Properties, Molecular Modeling, and Oral Delivery of Salmon Calcitonin
  publication-title: J. Med. Chem.
  doi: 10.1021/jm00021a014
  contributor:
    fullname: McInnes
– volume: 31
  start-page: 331
  year: 1979
  ident: ref_7
  article-title: Polycyanoacrylate Nanocapsules As Potential Lysosomotropic Carriers: Preparation, Morphological and Sorptive Properties
  publication-title: J. Pharm. Pharmacol.
  doi: 10.1111/j.2042-7158.1979.tb13510.x
  contributor:
    fullname: Couvreur
– volume: 49
  start-page: 109
  year: 2000
  ident: ref_57
  article-title: Insulin-Loaded Nanocapsules for Oral Administration: In Vitro and in Vivo Investigation
  publication-title: Drug Develop. Res.
  doi: 10.1002/(SICI)1098-2299(200002)49:2<109::AID-DDR4>3.0.CO;2-#
  contributor:
    fullname: Aboubakar
– volume: 18
  start-page: 286
  year: 1999
  ident: ref_11
  article-title: Antisense Oligonucleotide Delivery With Polyhexylcyanoacrylate Nanoparticles As Carriers
  publication-title: Methods
  doi: 10.1006/meth.1999.0786
  contributor:
    fullname: Zimmer
– volume: 13
  start-page: 233
  year: 1990
  ident: ref_56
  article-title: Nanocapsules As Carriers for Oral Peptide Delivery
  publication-title: J. Contr. Rel.
  doi: 10.1016/0168-3659(90)90013-J
  contributor:
    fullname: Michel
– volume: 41
  start-page: 2
  year: 1995
  ident: ref_5
  article-title: Controlled Drug Delivery With Nanoparticles: Current Possibilities and Future Trends
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Couvreur
– volume: 184
  start-page: 243
  year: 1999
  ident: ref_17
  article-title: Importance of the Test Medium for the Release Kinetics of a Somatostatin Analogue From Poly(D,L-Lactide-Co-Glycolide) Micropheres
  publication-title: Int. J. Pharm.
  doi: 10.1016/S0378-5173(99)00118-0
  contributor:
    fullname: Orsolini
– volume: 13
  start-page: 651
  year: 1996
  ident: ref_77
  article-title: PH-Dependent Microspheres From Modified Soybean Protein Hydrolysate
  publication-title: J. Microencaps.
  doi: 10.3109/02652049609026049
  contributor:
    fullname: Milstein
– volume: 6
  start-page: 691
  year: 1980
  ident: ref_50
  article-title: Intestinal Barrier to Large Particulates in Mice
  publication-title: J. Toxicol. Env. Health.
  doi: 10.1080/15287398009529888
  contributor:
    fullname: LeFevre
– volume: 183
  start-page: 3
  year: 1999
  ident: ref_22
  article-title: Nanospheres of Cyclosporin A: Poor Oral Absorption in Dogs
  publication-title: Int J Pharm
  doi: 10.1016/S0378-5173(99)00049-6
  contributor:
    fullname: Ford
– volume: 88
  start-page: 933
  year: 1999
  ident: ref_72
  article-title: Oral Delivery of Insulin Using pH-Responsive Complexation Gels
  publication-title: J. Pharm. Sci.
  doi: 10.1021/js980337n
  contributor:
    fullname: Lowman
– volume: 5
  start-page: 69
  year: 1988
  ident: ref_1
  article-title: Enzymatic Barriers to Peptide and Protein Absorption
  publication-title: CRC Crit. Rev. Ther. Drug Carrier Syst.
  contributor:
    fullname: Lee
– volume: 1
  start-page: 213
  year: 1968
  ident: ref_38
  article-title: The Phenomenon of Persorption
  publication-title: Digestion
  doi: 10.1159/000196856
  contributor:
    fullname: Volkheimer
– volume: 26
  start-page: 229
  year: 1993
  ident: ref_18
  article-title: In Vitro and in Vivo Evaluation of Clarithromycin/Poly(Lactic Acid) Microspheres for Intramuscular Drug Delivery
  publication-title: J. Contr. Rel.
  doi: 10.1016/0168-3659(93)90190-G
  contributor:
    fullname: Gupta
– volume: 28
  start-page: 125
  year: 1986
  ident: ref_25
  article-title: Development of a New Process for the Manufacture of Polyisobutylcyanoacrylate Nanocapsules
  publication-title: Int. J. Pharm
  doi: 10.1016/0378-5173(86)90236-X
  contributor:
    fullname: Fessi
– volume: 386
  start-page: 410
  year: 1997
  ident: ref_74
  article-title: Biologically Erodable Microspheres As Potential Oral Drug Delivery Systems
  publication-title: Nature
  doi: 10.1038/386410a0
  contributor:
    fullname: Mathiowitz
– volume: 14
  start-page: 163
  year: 1977
  ident: ref_35
  article-title: Persorption of Particles: Physiology and Pharmacology
  publication-title: Adv. Pharmaco. Chemother.
  doi: 10.1016/S1054-3589(08)60188-X
  contributor:
    fullname: Volkheimer
– volume: 8
  start-page: 531
  year: 1982
  ident: ref_19
  article-title: The Production and Evaluation of Orally Administred Insulin Nanoparticles
  publication-title: Drug Dev. Ind. Pharm.
  doi: 10.3109/03639048209022119
  contributor:
    fullname: Oppenheim
– volume: 42
  start-page: 65
  year: 1996
  ident: ref_20
  article-title: Co-Polymerised Peptide Particles (CPP) II: Oral Uptake of a Novel Co-Polymeric Nanoparticulate Delivery System for Peptides
  publication-title: J. Control. Rel.
  doi: 10.1016/0168-3659(96)01368-5
  contributor:
    fullname: Hillery
– volume: 214
  start-page: 25
  year: 2001
  ident: ref_14
  article-title: Comparison of Two Methods of Encapsulation of an Oligonucleotide into Poly(D,L-Lactic Acid) Particles
  publication-title: Int. J. Pharm.
  doi: 10.1016/S0378-5173(00)00627-X
  contributor:
    fullname: Delie
– volume: 43
  start-page: 1
  year: 1991
  ident: ref_24
  article-title: The Effect of Site of Administration in Gastrointestinal Tract on the Absorption of Insulin From Nanocapsules in Diabetic Rats
  publication-title: J. Pharm. Pharmacol.
  doi: 10.1111/j.2042-7158.1991.tb05437.x
  contributor:
    fullname: Michel
– volume: 5
  start-page: 171
  year: 1997
  ident: ref_68
  article-title: Improved Body Distribution of 14C-Labelled AZT Bound to Nanoparticles in Rats Determined by Radioluminography
  publication-title: J. Drug Targ.
  contributor:
    fullname: Maas
– volume: 41
  start-page: 271
  year: 1996
  ident: ref_21
  article-title: Co-Polymerised Peptide Particles (CPP) I: Synthesis, Charaterisation and in Vitro Studies on a Novel Oral Nanoparticulate Delivery System
  publication-title: J. Control. Rel.
  doi: 10.1016/0168-3659(96)01342-9
  contributor:
    fullname: Hillery
– volume: 42
  start-page: 345
  year: 1996
  ident: ref_29
  article-title: A New Nanocapsule Formulation With Hydrophilic Core: Application to the Oral Administration of Salmon Calcitonin in Rats
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Vranckx
– volume: 11
  start-page: 1270
  year: 1994
  ident: ref_9
  article-title: Preparation and Characterization of Novel Poly(Methylidene Malonate 2.1.2.)-Made Nanoparticles
  publication-title: Pharm. Res
  doi: 10.1023/A:1018986226557
  contributor:
    fullname: Lescure
– volume: 216A
  start-page: 257
  year: 1987
  ident: ref_47
  article-title: The Role of Peyer's Patches in Intestinal Humoral Immune Responses Is Limited to Memory Formation
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-1-4684-5344-7_30
  contributor:
    fullname: Jeurissen
– volume: 16
  start-page: 859
  year: 1999
  ident: ref_33
  article-title: Formulation and Lyoprotection of Poly(Lactic Acid-Co-Ethylene Oxide) Nanoparticles: Influence on Physical Stability and in Vitro Cell Uptake
  publication-title: Pharm. Res.
  doi: 10.1023/A:1018826103261
  contributor:
    fullname: Leroux
– volume: 6
  start-page: 153
  year: 1998
  ident: ref_46
  article-title: Binding and Uptake of Biodegradable Poly-DL-Lactide Micro- and Nanoparticles in Intestinal Epithelia
  publication-title: Eur. J. Pharm. Sci.
  doi: 10.1016/S0928-0987(97)10007-0
  contributor:
    fullname: McClean
– volume: 26
  start-page: 220
  year: 1980
  ident: ref_55
  article-title: Oral and Parenteral Administration of Insulin Associated to Hydrolysable Nanoparticles
  publication-title: Acta Pharm. Technol.
  contributor:
    fullname: Couvreur
– volume: 34
  start-page: 235
  year: 1998
  ident: ref_41
  article-title: Mucosal Immunity of the Gastrointestinal Tract and Oral Tolerance
  publication-title: Adv. Drug Del. Rev.
  doi: 10.1016/S0169-409X(98)00042-8
  contributor:
    fullname: Simecka
– volume: 11
  start-page: 1624
  year: 1976
  ident: ref_8
  article-title: In Vitro Studies of Poly(Methyl Methacrylate) Adjuvants
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.2600651115
  contributor:
    fullname: Kreuter
– volume: 40
  start-page: 134
  year: 1994
  ident: ref_69
  article-title: Improved Peroral Delivery of Avarol With Polybutylcyanoacrylate Nanoparticles
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Beck
– volume: 47
  start-page: 119
  year: 1999
  ident: ref_10
  article-title: Uptake of Oligonucleotide-Loaded Nanoparticles in Prostatic Cancer Cells and Their Intracellular Localization
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/S0939-6411(98)00064-2
  contributor:
    fullname: Berton
– volume: 17
  start-page: 707
  year: 2000
  ident: ref_30
  article-title: Polyisobutylcyanoacrylate Nanocapsules Containing an Aqueous Core As a Novel Colloidal Carrier for the Delivery of Oligonucleotides
  publication-title: Pharm.Res.
  doi: 10.1023/A:1007582332491
  contributor:
    fullname: Lambert
– volume: 1
  start-page: 8
  year: 1968
  ident: ref_40
  article-title: The Effect of Drugs on the Rate of Persorption
  publication-title: Pharmacology
  doi: 10.1159/000135938
  contributor:
    fullname: Volkheimer
– volume: 9
  start-page: 141
  year: 2001
  ident: ref_54
  article-title: In Vitro and in Vivo Evaluation of Poly(Methylidene Malonate 2.1.2) Microparticles Behavior for Oral Administration
  publication-title: J. Drug Target.
  doi: 10.3109/10611860108997924
  contributor:
    fullname: Couvreur
– volume: 39
  start-page: 173
  year: 1993
  ident: ref_3
  article-title: Drug Loaded Nanoparticles - Preparation Methods and Drug Targeting Issues
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Gurny
– volume: 7
  start-page: 71
  year: 1991
  ident: ref_34
  article-title: Peroral Administration of Nanoparticles
  publication-title: Adv. Drug Del. Rev.
  doi: 10.1016/0169-409X(91)90048-H
  contributor:
    fullname: Kreuter
– volume: 246
  start-page: 164
  year: 1975
  ident: ref_39
  article-title: Hematogenous Dissemination of Ingested Polyvinyl Chloride Particles
  publication-title: Proceed. Ann. N. Y. Acad. Sci.
  doi: 10.1111/j.1749-6632.1975.tb51092.x
  contributor:
    fullname: Volkheimer
– volume: 25
  start-page: 471
  year: 1999
  ident: ref_66
  article-title: Encapsulation of Hydrophilic and Lipophilic Drugs in PLGA Nanoparticles by the Nanoprecipitation Method
  publication-title: Drug Dev. Ind. Pharm.
  doi: 10.1081/DDC-100102197
  contributor:
    fullname: Barichello
– volume: 235
  start-page: 237
  year: 2002
  ident: ref_59
  article-title: Effect of Formulation Variables on Characteristics of Poly(Ethylcyanoacrylate) Nanocapsules Prepared From W/o Microemulsions
  publication-title: Int. J. Pharm.
  doi: 10.1016/S0378-5173(02)00002-9
  contributor:
    fullname: Watnasirichaikul
– volume: 38
  start-page: 4263
  year: 1995
  ident: ref_75
  article-title: N-Acylated α-Amino Acids As Novel Oral Delivery Agents for Proteins
  publication-title: J. Med. Chem.
  doi: 10.1021/jm00021a015
  contributor:
    fullname: Santiago
– volume: 84
  start-page: 1388
  year: 1995
  ident: ref_63
  article-title: Pharmacokinetics of a Novel HIV-1 Protease Inhibitor Incorporated into Biodegradable or Enteric Nanoparticles Following Intravenous and Oral Administration to Mice
  publication-title: J. Pharm. Sci.
  doi: 10.1002/jps.2600841202
  contributor:
    fullname: Leroux
– volume: 16
  start-page: 27
  year: 1991
  ident: ref_16
  article-title: Parenteral Depot-Systems on the Basis of Biodegradable Polyesters
  publication-title: J. Contr. Rel.
  doi: 10.1016/0168-3659(91)90028-C
  contributor:
    fullname: Kissel
– volume: 34
  start-page: 221
  year: 1998
  ident: ref_51
  article-title: Evaluation of Nano- and Microparticle Uptake by the Gastrointestinal Tract
  publication-title: Adv. Drug Del. Rev.
  doi: 10.1016/S0169-409X(98)00041-6
  contributor:
    fullname: Delie
– volume: 8
  start-page: 101
  year: 1991
  ident: ref_26
  article-title: Jejunal Absorption, Pharmacological Activity, and Pharmacokinetic Evaluation of Indomethacin-Loaded Poly(DL-Lactide) and Poly(Isobutyl-Cyanoacrylate) Nanocapsules in Rats
  publication-title: Pharm. Res.
  doi: 10.1023/A:1015846810474
  contributor:
    fullname: Ammoury
– volume: 34
  start-page: 171
  year: 1998
  ident: ref_2
  article-title: Polymeric Nano- and Microparticles for the Oral Delivery of Peptides and Peptidomimetics
  publication-title: Adv. Drug Del. Rev.
  doi: 10.1016/S0169-409X(98)00039-8
  contributor:
    fullname: Leroux
– volume: 34
  start-page: 305
  year: 1998
  ident: ref_44
  article-title: Microparticles and Polymers for the Mucosal Delivery of Vaccines
  publication-title: Adv. Drug Del. Rev.
  doi: 10.1016/S0169-409X(98)00045-3
– volume: 1
  start-page: 78
  year: 1968
  ident: ref_37
  article-title: Persorption of Particles
  publication-title: Digestion
  doi: 10.1159/000196836
  contributor:
    fullname: Volkheimer
– volume: 14
  start-page: 1568
  year: 1997
  ident: ref_53
  article-title: The Mechanism of Uptake of Biodegradable Microparticles in Caco-2 Cells Is Size Dependent
  publication-title: Pharm. Res.
  doi: 10.1023/A:1012126301290
  contributor:
    fullname: Desai
– volume: 13
  start-page: 485
  year: 1996
  ident: ref_71
  article-title: pH-Sensitive Nanoparticles: an Effective Means to Improve the Oral Delivery of HIV-1 Protease Inhibitor in Dogs
  publication-title: Pharm. Res.
  doi: 10.1023/A:1016073416332
  contributor:
    fullname: Leroux
– volume: 56
  start-page: 278
  year: 1988
  ident: ref_48
  article-title: Evidence for the Phagocytic Transfer of Intestinal Particles in Dogs and Rats
  publication-title: Infect. Immun.
  doi: 10.1128/iai.56.1.278-282.1988
  contributor:
    fullname: Wells
– volume: 15
  start-page: 581
  year: 1998
  ident: ref_70
  article-title: Methotrexate Loaded Chitosan and Chitin Microspheres - in Vitro Characterization and Pharmacokinetics in Mice Bearing Ehrlich Ascite Carcinoma
  publication-title: J. Microencaps.
  doi: 10.3109/02652049809008242
  contributor:
    fullname: Singh
– volume: 111
  start-page: 137
  year: 1994
  ident: ref_12
  article-title: Characterization of V3BRU Peptide Loaded Small PLGA Microspheres Prepared by (W1/O)W2 Emulsion Solvent Evaporation
  publication-title: Int. J. Pharm.
  doi: 10.1016/0378-5173(94)00104-9
  contributor:
    fullname: Delie
– volume: 77
  start-page: 203
  year: 1996
  ident: ref_4
  article-title: Nanoparticulate Drug Carrier Technology
  publication-title: Drugs Pharm. Sci.
  contributor:
    fullname: Alonso
– volume: 70
  start-page: 1
  year: 2001
  ident: ref_6
  article-title: Biodegradable Polymeric Nanoparticles As Drug Delivery Devices
  publication-title: J. Control. Release
  doi: 10.1016/S0168-3659(00)00339-4
  contributor:
    fullname: Soppimath
– volume: 5
  start-page: 223
  year: 1998
  ident: ref_64
  article-title: Assessment of the Activity of Atovaquone-Loaded Nanocapsules in the Treatment of Acute and Chronic Murine Toxoplasmosis
  publication-title: Parasite
  doi: 10.1051/parasite/1998053223
  contributor:
    fullname: Sordet
– volume: 49
  start-page: 949
  year: 1997
  ident: ref_58
  article-title: Poly(Alkyl Cyanoacrylate) Nanocapsules As a Delivery System in the Rat for Octreotide, a Long-Acting Somatostatin Analogue
  publication-title: J. Pharm. Pharmacol.
  contributor:
    fullname: Vonderscher
– volume: 37
  start-page: 246
  year: 1988
  ident: ref_23
  article-title: New Approach for Oral Administration of Insulin With Polyalkylcyanoacrylate Nanocapsules As Drug Carrier
  publication-title: Diabetes
  doi: 10.2337/diab.37.2.246
  contributor:
    fullname: Michel
– volume: 18
  start-page: 668
  year: 1991
  ident: ref_15
  article-title: Preparation and Characterization of Spray-Dried Poly(Dl-Lactide) Microspheres
  publication-title: Proceed. Int. Symp. Contr. Rel. Bioact. Mater.
  contributor:
    fullname: Bruhn
– volume: 65
  start-page: 261
  year: 2000
  ident: ref_60
  article-title: Nanospheres Based Oral Insulin Delivery
  publication-title: J. Contr. Rel.
  doi: 10.1016/S0168-3659(99)00247-3
  contributor:
    fullname: Carino
– volume: 146
  start-page: 59
  year: 1989
  ident: ref_43
  article-title: Biodegradable Microspheres: Vaccine Delivery System for Oral Immunization
  publication-title: Curr. Top. Microbiol. Immunol.
  contributor:
    fullname: Eldridge
– volume: 1
  start-page: 221
  year: 1991
  ident: ref_31
  article-title: Nanoparticle Characterization: a Comprehensive Physicochemical Approach
  publication-title: S.T.P.Pharma
  contributor:
    fullname: Magenheim
– volume: 2
  start-page: 608
  year: 1986
  ident: ref_27
  article-title: Procédé De Préparation De Systèmes Colloïdaux Dispersibles D'Une Substance, Sous Forme De Nanoparticules
  publication-title: Brevet français
  contributor:
    fullname: Fessi
SSID ssj0021415
Score 2.1843808
SecondaryResourceType review_article
Snippet Oral administration remains the most convenient way of delivering drugs. Recent advances in biotechnology have produced highly potent new molecules such as...
SourceID doaj
pubmedcentral
proquest
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 65
SubjectTerms Administration, Oral
Animals
Biological Availability
calcitonin
Gastrointestinal Tract - drug effects
Gastrointestinal Tract - metabolism
Humans
insulin
Intestinal Absorption - drug effects
mechanisms of absorption
microparticle
Models, Biological
Nanoparticle
Nanoparticles - administration & dosage
Nanoparticles - chemistry
oral route
Particle Size
peptide
Peptides - administration & dosage
Peptides - pharmacokinetics
Pharmaceutical Preparations - administration & dosage
Polymers - chemical synthesis
Polymers - chemistry
Polymers - pharmacokinetics
protein
Review
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrZ1LT4QwEMcb3YtejG_R1dTEK1laCoWj-3JPuomaeCOlndVNNovZh8l-e6cFVteYeDGcoAkZZoD5D7S_IeRGpREHjc-3iETsizRO_dRo4aOYCMJQhTLJ7drhwaO8f0m6PYvJWbf6snPCSjxw6bhWqlDTGzWCUObCGKNwR4AOlA60NAzc2zeQdTFVlVpMuN4FTNj1wSiCS-xsiAV-y0KHbOLdSESO1_-byPw5V_Jb8unvk71KNdLb0toDsgXTQ7LTqZu1HZG7YTFZuZ8vdOiuyXblgjldFLT8bAD0Ac9L2-NCfajxpKRzr2gxokM7r8UA7c6Wr_Nj8tzvPXUGftUjwddRGCx8xpXiPNXCALNgGYgThmkvAmlyoZQGxYMIDNNKo-tiVG_RKGfcoKg2uYIkPCGNaTGFM0IDAzwZcTBSCAEcFMuxGLGIKWORO9Ij17XDsvcShZFhCWGdmtVO9UjbenI9buHV7gCGNKtCmv0VUo806zhk1RM1z_DNbFcs4OaR0zIkX1YkFoAu0UK5EawNMzZHpuM3x9JGdSKjKD7_D7svyK4DuwYMM1uTNBazJVyS7blZXrm78xMEcuwB
  priority: 102
  providerName: Directory of Open Access Journals
Title Polymeric particulates to improve oral bioavailability of peptide drugs
URI https://www.ncbi.nlm.nih.gov/pubmed/18007277
https://www.proquest.com/docview/1531108080
https://pubmed.ncbi.nlm.nih.gov/PMC6147556
https://doaj.org/article/9a287dafe37b4ddda7da4ec0ac0c7d1e
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ1Nb9QwEIZHbC9wQXyTtlRG4ppu7NhxcqTbll6AlQCJW-R4ZstK26TaD6T--46dBFjECeWWKNFoxs7Mm4wfA7xzlVHkeX5ro4tUV0WVVuh1ysVElucut2UT1g5ffbGfvpfnFwGTY8a1MLFp3zfL03Z1c9ouf8TeytsbPx37xKbzjzNOKdaYYjqBCdeGo0QfVJbklNRTZnPW89PAGAp5NtBBy8DJtnYvBUVS_7_Ky7-7JP9IO5dP4PFQL4r3vV1P4QG1z-DhbNym7Tl8mHeru_jbRcyj9WE_LtqIbSf6DwYkPvNzxdmycz_dctVzue9EtxDz0NGCJM7Xu-vNC_h2efF1dpUOuyOk3uTZNpXKOaUqr5FkQMpQUUpOeIYsNto5T05lhlB659HZgus2s2ikQi6nsXFU5i_hoO1aeg0iQ1LlQhFarTUpcrJhGRLgUhhgOzaBt6PD6tseglGzeAj-rUf_JnAWPPnresBWxxPd-roegldXjgUaugXlttGIbBc6TT5zPvMWJSVwPMahHubSpuZ3clirwEcCr_qQ_LZiCGkCdi9Ye2bsX-FBFSnawyA6_O87j-BR5LhmkhPZMRxs1zt6A5MN7k6isj-J4_IeKdHo_g
link.rule.ids 230,314,315,729,782,786,794,866,887,2107,27932,27934,27935,53802,53804
linkProvider National Library of Medicine
linkToHtml http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3Lb9QwEIdHfRzKBSjPQGmNxDXd2LHj5Ei3j61oy0oUiVvk2LNlpW1S7QOp_z1jJwEW9VTlFivRyD87MxOPPwN8MoUSaGl-SyWzWBZZERfOypiCiSRNTarzyu8dHn3TVz_y4xOPyVH9XphQtG-r6WE9uz2spz9DbeXdrR30dWKD8eWQXIpWKhtswjbN10T0SXqXZ3FySi1nNqWMfuApQ97Tej5o7knZWq85ocDqfyjA_L9O8h_Hc_rskSY_h6ddpMk-t827sIH1C9gZ9ge8vYSzcTO7Dws2bBxe4k_ywgVbNqz91YDsK9nDjqaN-WWms5bofc-aCRv7WhiH7Hi-ulm8gu-nJ9fDUdydqxBblSbLmAtjhCisdMg9jAaznJOrVKhdJY2xaESi0HFrrDM6o4hPTSouHAXirjKYp69hq25qfAsscSjyiUCnpZQo0PCKEhiPpXIe06Mj-Nh3dHnX4jNKSju8LmWvSwRHXoE_7R54HW4085uy68OyMJTaOTPBVFfSObLLGYk2MTax2nGMYK_Xr-xm4aKkr7nf5UBXBG9aKf9a0Q2FCPSayGtmrLeQtoG_3Wn57tFPHsDO6Pryorw4v_ryHp4EGmzCyR3uwdZyvsIPsLlwq_0wqn8DimT9lQ
linkToPdf http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV1Nb9QwEB3RIgGX8k0DBYzENU3sOHFypLtdioASCZC4RY5nUlbaJqv9QOq_x3aSwiJOoNziJBr5efJmkvEbgNe6SAUZ698ylVkoi6wICzQytMFEnCQ6UXnt9g6ffVbn3_LpqZPJuW715Yv2TT0_bheXx-38u6-tXF6aaKwTi8qPE0spKk2zaIlNtAc3rc_GckzUh1yLW2LqtWYTm9VHTmnIsa3TCM2dWrZSO0Tk9fr_FmT-WSv5G_nM7v6H2ffgYIg42Zv-kvtwg9oHcHsyNnp7CG_LbnHlf9yw0j_IdfSiNdt0rP_kQOyTtYmdzDv9Q88XvbL3FesaVrqaGCQ2XW0v1o_g6-z0y-QsHPorhCZN4k3IhdZCFEYicSdKQ1nOLWWmpLCWWhvSIk4JudEGtcps5Jc2NRdoA3KsNeXJY9hvu5YOgcVIIm8EoZJSkiDNa5vIOHkqdHI9KoBX42RXy15Go7Lph8OmGrEJ4MShcD3uhK_9iW51UQ3zWBXapnioG0pULRGtXaglmVib2CjkFMDRiGE1eOO6sm91t9vBHgE86eH8ZcWwHAJQO0DvmLE7YvH1OtwDnk__-c6XcKuczqoP787fP4M7XhQ25pYVj2B_s9rSc9hb4_aFX9g_AX1dACQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Polymeric+Particulates+to+Improve+Oral+Bioavailability+of+Peptide+Drugs&rft.jtitle=Molecules+%28Basel%2C+Switzerland%29&rft.au=Delie%2C+Florence&rft.au=Blanco-Pr%C3%ADeto%2C+Mar%C3%ADa+Jose&rft.date=2005-01-31&rft.pub=MDPI+AG&rft.eissn=1420-3049&rft.volume=10&rft.issue=1&rft.spage=65&rft_id=info:doi/10.3390%2F10010065&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=3321822561
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1420-3049&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1420-3049&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1420-3049&client=summon